Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Antisense Therapeutics Ltd. (ATHJF) Starts Presentation at 25th Annual ROTH Conference

Antisense Therapeutics is an Australian pharmaceutical drug discovery and development company focused on creating, developing and commercializing novel antisense therapeutics. The company’s strategy involves creating antisense drugs, in collaboration with technology and research partners, that address diseases for which there are large and/or poorly met markets; outsourcing preclinical and clinical testing of candidate drugs to expert contractors; and commercializing drugs with preclinical or clinical testing success through licensing deals or other partnerships with major pharmaceutical companies. For more information, visit the company’s Web site: http://www.antisense.com.au

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *